Cellebrite Di Ltd (CLBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 78,326 | -283,007 | -81,100 | 120,805 | 71,396 |
| Depreciation Amortization | 9,496 | 7,703 | 8,905 | 8,822 | 7,007 |
| Income taxes - deferred | 75 | -4,015 | 5,125 | -2,392 | -1,638 |
| Accounts receivable | -15,781 | -5,829 | 2,271 | -12,885 | -1,958 |
| Accounts payable and accrued liabilities | 4,943 | 2,755 | 3,691 | -5,471 | 4,239 |
| Other Working Capital | 46,605 | 42,047 | 38,519 | -2,819 | 20,680 |
| Other Operating Activity | 49,880 | 372,517 | 124,647 | -85,483 | -63,674 |
| Operating Cash Flow | $173,544 | $132,171 | $102,058 | $20,577 | $36,052 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -107,569 | -136,116 | -14,622 | -82,146 | 73,337 |
| PPE Investments | -160,681 | -11,314 | -5,231 | -6,897 | -5,111 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -20,000 |
| Purchase Sale Intangibles | N/A | -2,043 | -2,687 | -2,188 | -3,000 |
| Other Investing Activity | 0 | -2,043 | -2,687 | -2,188 | -3,000 |
| Investing Cash Flow | $-268,250 | $-149,473 | $-22,540 | $-91,231 | $45,226 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 25,053 | 20,662 | 21,765 | 13,970 | 2,305 |
| Common Stock Repurchased | N/A | -11 | N/A | N/A | N/A |
| Dividend Paid | N/A | N/A | N/A | N/A | -100,000 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 29,298 |
| Financing Cash Flow | $25,053 | $20,651 | $21,765 | $13,970 | $-68,397 |
| Exchange Rate Effect | 2,451 | -1,207 | 589 | -1,644 | -754 |
| Beginning Cash Position | 191,659 | 189,517 | 87,645 | 145,973 | 133,846 |
| End Cash Position | 124,457 | 191,659 | 189,517 | 87,645 | 145,973 |
| Net Cash Flow | $-67,202 | $2,142 | $101,872 | $-58,328 | $12,127 |
| Free Cash Flow | |||||
| Operating Cash Flow | 173,544 | 132,171 | 102,058 | 20,577 | 36,052 |
| Capital Expenditure | -160,681 | -11,314 | -5,231 | -6,897 | -5,111 |
| Free Cash Flow | 12,863 | 120,857 | 96,827 | 13,680 | 30,941 |